Amsterdam, 20 July 2009 – Elsevier, the leading publisher of scientific, technical and medical information products and services, today announces the 'Article of the Future' project, an ongoing collaboration with the scientific community to redefine how a scientific article is presented online. The project takes full advantage of online capabilities, allowing readers individualized entry points and routes through content, while exploiting the latest advances in visualization techniques.
The Article of the Future launches its first prototypes this week, revealing a new approach to presenting scientific research online. The key feature of the prototypes is a hierarchical presentation of text and figures so that readers can elect to drill down through the layers based on their current task in the scientific workflow and their level of expertise and interest. This organizational structure is a significant departure from the linear-based organization of a traditional print-based article in incorporating the core text and supplemental material within a single unified structure.
A second key feature of the prototypes is bulleted article highlights and a graphical abstract. This allows readers to quickly gain an understanding of the paper's main 'take home' message and serves as a navigation mechanism to directly access specific sub-sections of the results and figures. The graphical abstract is intended to encourage browsing, promote interdisciplinary scholarship and help readers identify more quickly which papers are most relevant to their research interests.
Emilie Marcus, Editor in Chief, Cell Press commented, "The genesis of the 'Article of the Future' project came from a challenge to redesign from scratch how to most effectively structure and present the content of a traditional scientific article in an online environment. The rapid pace of technological advancements means this will undoubtedly be an evolving design, but we are happy to be able to address some key reader and author pain points such as the integration of supplemental data with these initial prototypes. We are tremendously excited that authors contributing to Cell Press journals will have the opportunity to pioneer this new concept and make a significant contribution to its development."
The prototypes have been developed by the editorial, production and IT teams at Cell Press in collaboration with Elsevier's User Centered Design group using content from two previously published Cell articles. They can be viewed at http://beta.cell.com where Elsevier and Cell Press are inviting feedback from the scientific community on the concepts and implementations. Successful ideas from this project will ultimately be rolled-out across Elsevier's portfolio of 2,000 journals available on ScienceDirect.
"Together with the 2009 Elsevier Grand Challenge, the 'Article of the Future' project forms part of Elsevier's commitment to collaborating with our scientific community on Content Innovation. Sharing these prototypes and inviting feedback is the next step," remarked IJsbrand Jan Aalbersberg, Vice President of Content Innovation for Elsevier Science & Technology Journal Publishing, "We are confident that these tools will enhance the presentation of scientific results and improve the interpretation and speed of results analysis. They are central to driving innovation in scientific publishing and represent our investment in the future of research, enabling scientists all over the world to access, interpret, and create better science more efficiently."
Notes to Editors:
The Article of the Future prototype can be viewed at http://beta.cell.com where Elsevier is inviting scientific community feedback on the concept.
The Elsevier Grand Challenge (www.elseviergrandchallenge.com) is a contest created to improve the way scientific information is communicated and used. The contest invites members of the scientific community to describe and prototype a tool to improve the interpretation and identification of meaning in (online) journals and text databases relating to the life sciences.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
About Cell Press
Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the scientific community it serves. Cell Press primary research journals include the flagship journal Cell, as well as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry & Biology, Cell Metabolism, Cell Host & Microbe, Cell Stem Cell, and, new to Cell Press, Biophysical Journal, and the American Journal of Human Genetics. Cell Press also publishes the Trends family of reviews journals, including Trends in Cell Biology, Trends in Neurosciences, and Trends in Cognitive Sciences. (www.cell.com)
Media Contacts:
Neil Hallmark
Kaizo
+44 20 3043 4182
elsevier@kaizo.net
Ylann Schemm
Elsevier
+31 623982359
+1 2126333640
y.schemm@elsevier.com
Cathleen Genova
Cell Press
617-397-2802 (office)
cgenova@cell.com